Indications and Donor Selections for Allogeneic Stem Cell Transplantation in Children with Hematologic Malignancies-Reference-Cited by-同舟云学术

Indications and Donor Selections for Allogeneic Stem Cell Transplantation in Children with Hematologic Malignancies

Published:2008-02 Issue:1 Volume:55 Page:71-96
ISSN:0031-3955
Container-title:Pediatric Clinics of North America
language:en
Short-container-title:Pediatric Clinics of North America

Author:

Handgretinger Rupert,Kurtzberg Joanne,Egeler R. Maarten

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference148 articles.

1. Childhood acute lymphoblastic leukaemia—current status and future perspectives;Pui;Lancet Oncol,2001

2. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

3. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse—the Children's Cancer Group Experience;Gaynon;Cancer,1998

4. Hematologic malignancies with t(4;11)(q21;q23)—a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants;Johansson;Leukemia,1998

5. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group;Heerema;Blood,1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome;Journal of Pediatric Hematology/Oncology;2020-05-15

2. Hematopoietic Cell Transplantation and Cellular Therapeutics in the Treatment of Childhood Malignancies;Pediatric Clinics of North America;2015-02

3. Alternative donor HSCT in refractory acquired aplastic anemia: The time has come;Pediatric Transplantation;2012-05-30

4. Surgical management of stem cell transplantation-related complications in children;Pediatric Transplantation;2012-05-14

5. Access to allogeneic hematopoietic SCT for patients with MDS or relapsed AML treated according to protocols of the Dutch Childhood Oncology Group;Bone Marrow Transplantation;2011-08-22